BAJAJ BROKING

Notification close image
No new Notification messages
card image
Anondita Medicare IPO is Open!
Apply for the Anondita Medicare IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

543207

NATURAL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Natural Biocon (India) Limited Share Price Update

As of the latest trading session, Natural Biocon (India) Limited share price is currently at ₹ 8.19, which is up by ₹ 0.21 from its previous closing. Today, the stock has fluctuated between ₹ 8.00 and ₹ 8.19. Over the past year, Natural Biocon (India) Limited has achieved a return of -33.49 %. In the last month alone, the return has been -33.33 %. Read More...

Investment Returns

Over 1 Month -33.33% Over 3 Months -24.39% Over 6 Months -37.07% Over 1 Year -33.49%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Natural Biocon (India) Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    21.00

  • P/E Ratio (TTM)

    199.25

  • Beta

    0.36

  • Book Value / share

    12.36

  • Return on equity

    1.22%

  • EPS (TTM)

    0.04

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.14

info icon alternate text

Natural Biocon (India) Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2025 (Values in Cr)
Revenue 1.67
Operating Expense 1.53
Net Profit 0.14
Net Profit Margin (%) 8.38
Earnings Per Share (EPS) 0.05
EBITDA 0.14
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 1.35
Operating Expense 1.84
Net Profit -0.49
Net Profit Margin (%) -36.29
Earnings Per Share (EPS) -0.19
EBITDA -0.49
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 1.28
Operating Expense 1.03
Net Profit 0.25
Net Profit Margin (%) 19.53
Earnings Per Share (EPS) 0.10
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 4.74
Operating Expense 4.53
Net Profit 0.20
Net Profit Margin (%) 4.21
Earnings Per Share (EPS) 0.08
EBITDA 0.20
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.99
Operating Expense 0.89
Net Profit 0.10
Net Profit Margin (%) 10.10
Earnings Per Share (EPS) 0.08
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 8.35
Operating Expense 8.29
Net Profit 0.04
Net Profit Margin (%) 0.47
Earnings Per Share (EPS) 0.02
EBITDA 0.06
Effective Tax Rate (%) 33.33
Particulars MAR 2024 (Values in Cr)
Revenue 13.53
Operating Expense 13.31
Net Profit 0.15
Net Profit Margin (%) 1.10
Earnings Per Share (EPS) 0.13
EBITDA 0.23
Effective Tax Rate (%) 30.43
Particulars MAR 2023 (Values in Cr)
Revenue 1.25
Operating Expense 1.01
Net Profit 0.18
Net Profit Margin (%) 14.39
Earnings Per Share (EPS) 0.15
EBITDA 0.25
Effective Tax Rate (%) 28.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.48
Operating Expense 0.39
Net Profit 0.07
Net Profit Margin (%) 14.58
Earnings Per Share (EPS) 0.06
EBITDA 0.09
Effective Tax Rate (%) 22.22
Particulars MAR 2021 (Values in Cr)
Revenue 0.13
Operating Expense 0.13
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 10.89
ROE % 1.22
ROCE % 1.77
Total Debt to Total Equity 0.01
EBITDA Margin 1.70
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.75
ROE % 1.48
ROCE % 2.03
Total Debt to Total Equity 0.01
EBITDA Margin 20.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.60
ROE % 0.58
ROCE % 0.73
Total Debt to Total Equity 0.02
EBITDA Margin 18.75
Particulars MAR 2021 (Values in Cr)
Book Value / Share 10.54
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.04
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 10.54
ROE % -0.67
ROCE % -0.24
Total Debt to Total Equity 0.06
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 16.76
Total Liabilities 16.76
Total Equity 12.38
Share Outstanding 11372800
Price to Book Ratio 0.94
Return on Assets (%) 0.91
Return on Capital (%) 1.23
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.40
Total Assets 13.51
Total Liabilities 13.51
Total Equity 12.23
Share Outstanding 11372800
Price to Book Ratio 0.43
Return on Assets (%) 1.32
Return on Capital (%) 1.45
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 12.29
Total Liabilities 12.29
Total Equity 12.05
Share Outstanding 11372800
Price to Book Ratio 0.85
Return on Assets (%) 0.53
Return on Capital (%) 0.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 12.37
Total Liabilities 12.37
Total Equity 11.98
Share Outstanding 11372800
Price to Book Ratio 0.00
Return on Assets (%) 0.02
Return on Capital (%) 0.02
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 12.71
Total Liabilities 12.71
Total Equity 11.98
Share Outstanding 11372800
Price to Book Ratio 0.00
Return on Assets (%) -0.62
Return on Capital (%) -0.63
Particulars MAR 2024 (Values in Cr)
Net Income 0.22
Cash from Operations -0.05
Cash from Investing 0.00
Cash from Financing -0.08
Net change in Cash -0.21
Free Cash Flow -0.05
Particulars MAR 2023 (Values in Cr)
Net Income 0.24
Cash from Operations 0.27
Cash from Investing 0.00
Cash from Financing -0.01
Net change in Cash 0.19
Free Cash Flow 0.27
Particulars MAR 2022 (Values in Cr)
Net Income 0.08
Cash from Operations 0.20
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.17
Free Cash Flow 0.20
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.32
Cash from Investing 0.00
Cash from Financing -0.32
Net change in Cash 0.00
Free Cash Flow 0.32
Particulars MAR 2020 (Values in Cr)
Net Income -0.03
Cash from Operations 0.15
Cash from Investing 0.00
Cash from Financing -0.14
Net change in Cash 0.00
Free Cash Flow 0.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRENT LTD 5452.15 122.38 35.48 193817.10 4491.75 / 8345.85
WARREN TEA LTD. 58.57 47.23 0.71 69.99 39.70 / 86.00
MULLER & PHIPPS (INDIA) LTD. 264.75 0.00 -7.97 16.55 215.75 / 726.20
FUTURE ENTERPRISES LTD 0.57 0.00 -0.09 42.86 0.56 / 0.95
UVS HOSPITALITY AND SERVICES L 140.00 30.37 3.19 501.38 91.40 / 236.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRENT LTD 5452.15 116.40 32.77 193817.10 4491.75 / 8345.85
Saptak Chem And Business Limit 4.50 0.00 -2.13 4.83 2.40 / 5.65
WARREN TEA LTD. 58.57 201.97 0.79 69.99 39.70 / 86.00
MULLER & PHIPPS (INDIA) LTD. 264.75 0.00 -7.97 16.55 215.75 / 726.20

Natural Biocon (India) Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
8.14 2.13 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 8.30
  • 26 Days 10.20
  • 10 Days 8.90
  • 50 Days 11.10
  • 12 Days 9.10
  • 100 Days 11.80
  • 20 Days 9.80
  • 200 Days 12.20
8.22 PIVOT

First Support

7.98

First Resistance

8.41

Second Support

7.79

Second Resistance

8.65

Third Support

7.55

Third Resistance

8.84

RSI

25.12

ADX

42.00

MACD

-1.10

Williams % R

-94.77

Commodity Channel Index (CCI)

-98.48

Date

2025-08-20

Week

411745.00

Same Day

18250.00

Month

426543.00

1 Year

0.36

3 Year

0.47

Over 1 Month

-33.33%

down

Over 1 Year

-33.49%

down

Over 3 Months

-24.39%

down

Over 3 Years

19.28%

down

Over 6 Months

-37.07%

down

Over 5 Years

-12.12%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Natural Biocon (India) Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Natural Biocon (India) Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Natural Biocon (India) Limited Share Price

Natural Biocon (India) Ltd (NBL), was incorporated as a Public Limited Company on 27th August, 1992 and obtained a Certificate of Commencement of Business on 8th September, 1992. The Company was a pioneer manufacturer of natural color based on modern technology.

Presently, the Company is engaged in the business of chemicals, natural extracts and agricultural produces. The Company's principal revenue stream is retail trading of agricultural produce and commodities. Food color manufactured from Bixa orellana is in natural form and hence it is least harmful on human health as compared with synthetic colors which cause cancer in various parts of the body besides being the cause of number of diseases. Owing to such reasons, world-wide restriction have been imposed against use of coal-tar colors and world health, food and drug authorities have restricted the use of coal-tar color in consumables while some of the European countries have virtually banned the use of coal-tar color and hence strictly restricted its uses especially in consumable items.

Hence, the Management of the Company decided to venture into the chemical and agriculture produce, also due to which some of the region of the State of Gujarat were selected for trading in the chemical and agriculture produce segment to various related industries. The Company received good response in the chemical and agriculture produce segment.

The Company came out with a new project, Norbixin (Natural Food Colour) with an installed capacity of 180 TPA at Gujarat. It proposed to manufacture Bixa Orellana Seeds as the main material of Natural Food Colour, for this, it developed Nucleus Farm costing Rs. 1.80 crores.

To meet the above expenses, the Company came out with a Public Issue of 76,25,000 Equity Share of Rs. 10/- each for cash at par aggregating Rs. 7.63 crores.

Parent organization Indian Private
NSE symbol [-]
Founded 1992
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of ?

Answer Field

share price is for NSE ₹ & for BSE ₹ as on Aug 22 2025 03:28 PM.

What is the Market Cap of Share?

Answer Field

The market cap of for NSE ₹ & for BSE ₹ as on Aug 22 2025 03:28 PM.

What is the 52 Week High and Low of ?

Answer Field

The 52 Week High and Low of for NSE is ₹ and ₹ and for BSE is ₹ and ₹ .

What is 1 year return for ?

Answer Field

The 1 year returns on the stock has been %.

What is the P/E Ratio of Share?

Answer Field

As on Aug 22 2025 03:28 PM the price-to-earnings (PE) ratio for share is 199.25.

What is the PB ratio of Share?

Answer Field

As on Aug 22 2025 03:28 PM, the price-to-book (PB) ratio for share is 12.36.

How to Buy Share on Bajaj Broking App?

Answer Field

To buy shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91